L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
Identifieur interne : 001C46 ( PubMed/Checkpoint ); précédent : 001C45; suivant : 001C47L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
Auteurs : H. Mars ; I. Libman ; A M Schwartz ; L. Gillo-Joffroy ; A. BarbeauSource :
- Canadian Psychiatric Association journal [ 0008-4824 ] ; 1972.
English descriptors
- KwdEn :
- Administration, Oral, Aged, Basal Ganglia Diseases (chemically induced), Constipation (chemically induced), Dihydroxyphenylalanine (administration & dosage), Dihydroxyphenylalanine (adverse effects), Dihydroxyphenylalanine (therapeutic use), Evaluation Studies as Topic, Humans, Hypotension (chemically induced), Movement Disorders (chemically induced), Nausea (chemically induced), Parkinson Disease (drug therapy), Quebec, Time Factors, Vomiting (chemically induced).
- MESH :
- chemical , administration & dosage : Dihydroxyphenylalanine.
- chemical , adverse effects : Dihydroxyphenylalanine.
- geographic : Quebec.
- chemically induced : Basal Ganglia Diseases, Constipation, Hypotension, Movement Disorders, Nausea, Vomiting.
- drug therapy : Parkinson Disease.
- chemical , therapeutic use : Dihydroxyphenylalanine.
- Administration, Oral, Aged, Evaluation Studies as Topic, Humans, Time Factors.
PubMed: 5036506
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:5036506Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.</title><author><name sortKey="Mars, H" sort="Mars, H" uniqKey="Mars H" first="H" last="Mars">H. Mars</name></author><author><name sortKey="Libman, I" sort="Libman, I" uniqKey="Libman I" first="I" last="Libman">I. Libman</name></author><author><name sortKey="Schwartz, A M" sort="Schwartz, A M" uniqKey="Schwartz A" first="A M" last="Schwartz">A M Schwartz</name></author><author><name sortKey="Gillo Joffroy, L" sort="Gillo Joffroy, L" uniqKey="Gillo Joffroy L" first="L" last="Gillo-Joffroy">L. Gillo-Joffroy</name></author><author><name sortKey="Barbeau, A" sort="Barbeau, A" uniqKey="Barbeau A" first="A" last="Barbeau">A. Barbeau</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1972">1972</date><idno type="RBID">pubmed:5036506</idno><idno type="pmid">5036506</idno><idno type="wicri:Area/PubMed/Corpus">001D38</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D38</idno><idno type="wicri:Area/PubMed/Curation">001D38</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D38</idno><idno type="wicri:Area/PubMed/Checkpoint">001D38</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001D38</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.</title><author><name sortKey="Mars, H" sort="Mars, H" uniqKey="Mars H" first="H" last="Mars">H. Mars</name></author><author><name sortKey="Libman, I" sort="Libman, I" uniqKey="Libman I" first="I" last="Libman">I. Libman</name></author><author><name sortKey="Schwartz, A M" sort="Schwartz, A M" uniqKey="Schwartz A" first="A M" last="Schwartz">A M Schwartz</name></author><author><name sortKey="Gillo Joffroy, L" sort="Gillo Joffroy, L" uniqKey="Gillo Joffroy L" first="L" last="Gillo-Joffroy">L. Gillo-Joffroy</name></author><author><name sortKey="Barbeau, A" sort="Barbeau, A" uniqKey="Barbeau A" first="A" last="Barbeau">A. Barbeau</name></author></analytic><series><title level="j">Canadian Psychiatric Association journal</title><idno type="ISSN">0008-4824</idno><imprint><date when="1972" type="published">1972</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Basal Ganglia Diseases (chemically induced)</term><term>Constipation (chemically induced)</term><term>Dihydroxyphenylalanine (administration & dosage)</term><term>Dihydroxyphenylalanine (adverse effects)</term><term>Dihydroxyphenylalanine (therapeutic use)</term><term>Evaluation Studies as Topic</term><term>Humans</term><term>Hypotension (chemically induced)</term><term>Movement Disorders (chemically induced)</term><term>Nausea (chemically induced)</term><term>Parkinson Disease (drug therapy)</term><term>Quebec</term><term>Time Factors</term><term>Vomiting (chemically induced)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dihydroxyphenylalanine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dihydroxyphenylalanine</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Quebec</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Basal Ganglia Diseases</term><term>Constipation</term><term>Hypotension</term><term>Movement Disorders</term><term>Nausea</term><term>Vomiting</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dihydroxyphenylalanine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Evaluation Studies as Topic</term><term>Humans</term><term>Time Factors</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">5036506</PMID><DateCreated><Year>1972</Year><Month>08</Month><Day>19</Day></DateCreated><DateCompleted><Year>1972</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0008-4824</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>1972</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Canadian Psychiatric Association journal</Title><ISOAbbreviation>Can Psychiatr Assoc J</ISOAbbreviation></Journal><ArticleTitle>L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.</ArticleTitle><Pagination><MedlinePgn>123-31</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mars</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Libman</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Gillo-Joffroy</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Barbeau</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Psychiatr Assoc J</MedlineTA><NlmUniqueID>0414266</NlmUniqueID><ISSNLinking>0008-4824</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63-84-3</RegistryNumber><NameOfSubstance UI="D004295">Dihydroxyphenylalanine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001480" MajorTopicYN="N">Basal Ganglia Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="N">Constipation</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004295" MajorTopicYN="N">Dihydroxyphenylalanine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005069" MajorTopicYN="N">Evaluation Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009069" MajorTopicYN="N">Movement Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011792" MajorTopicYN="N" Type="Geographic">Quebec</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014839" MajorTopicYN="N">Vomiting</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1972</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1972</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1972</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">5036506</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Barbeau, A" sort="Barbeau, A" uniqKey="Barbeau A" first="A" last="Barbeau">A. Barbeau</name><name sortKey="Gillo Joffroy, L" sort="Gillo Joffroy, L" uniqKey="Gillo Joffroy L" first="L" last="Gillo-Joffroy">L. Gillo-Joffroy</name><name sortKey="Libman, I" sort="Libman, I" uniqKey="Libman I" first="I" last="Libman">I. Libman</name><name sortKey="Mars, H" sort="Mars, H" uniqKey="Mars H" first="H" last="Mars">H. Mars</name><name sortKey="Schwartz, A M" sort="Schwartz, A M" uniqKey="Schwartz A" first="A M" last="Schwartz">A M Schwartz</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C46 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C46 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:5036506
|texte= L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:5036506" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |